| __timestamp | Alnylam Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 49605000000 |
| Thursday, January 1, 2015 | 41097000 | 48851000000 |
| Friday, January 1, 2016 | 47159000 | 52824000000 |
| Sunday, January 1, 2017 | 89912000 | 52546000000 |
| Monday, January 1, 2018 | 74908000 | 53647000000 |
| Tuesday, January 1, 2019 | 219750000 | 51750000000 |
| Wednesday, January 1, 2020 | 492853000 | 41908000000 |
| Friday, January 1, 2021 | 844287000 | 81288000000 |
| Saturday, January 1, 2022 | 1037418000 | 100330000000 |
| Sunday, January 1, 2023 | 1828292000 | 58496000000 |
| Monday, January 1, 2024 | 2248243000 | 63627000000 |
Cracking the code
In the ever-evolving landscape of pharmaceuticals, revenue performance is a key indicator of a company's market position and growth potential. This chart provides a fascinating comparison between two industry players: Pfizer Inc. and Alnylam Pharmaceuticals, Inc., from 2014 to 2023.
Pfizer, a titan in the pharmaceutical world, consistently demonstrated robust revenue figures, peaking in 2022 with a staggering 100% increase compared to 2014. This growth underscores Pfizer's strategic prowess and adaptability in a competitive market.
Conversely, Alnylam Pharmaceuticals, a smaller yet innovative player, showcased an impressive growth trajectory. From a modest start in 2014, Alnylam's revenue surged by over 3,500% by 2023, highlighting its rapid expansion and potential in niche markets.
This comparison not only reflects the diverse strategies of these companies but also offers insights into the dynamic nature of the pharmaceutical industry.
Pfizer Inc. vs Supernus Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Amgen Inc. vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Genmab A/S
Alnylam Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.: Annual Revenue Growth Compared
Alnylam Pharmaceuticals, Inc. vs Grifols, S.A.: Annual Revenue Growth Compared
Alnylam Pharmaceuticals, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Bausch Health Companies Inc.?
Alnylam Pharmaceuticals, Inc. and Vericel Corporation: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Generates More Revenue? Alnylam Pharmaceuticals, Inc. or Dynavax Technologies Corporation